1. Home
  2. CGCT vs TMCI Comparison

CGCT vs TMCI Comparison

Compare CGCT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGCT
  • TMCI
  • Stock Information
  • Founded
  • CGCT 2024
  • TMCI 2014
  • Country
  • CGCT United States
  • TMCI United States
  • Employees
  • CGCT N/A
  • TMCI N/A
  • Industry
  • CGCT
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CGCT
  • TMCI Health Care
  • Exchange
  • CGCT NYSE
  • TMCI Nasdaq
  • Market Cap
  • CGCT 345.0M
  • TMCI 371.1M
  • IPO Year
  • CGCT 2025
  • TMCI 2021
  • Fundamental
  • Price
  • CGCT N/A
  • TMCI $6.18
  • Analyst Decision
  • CGCT
  • TMCI Hold
  • Analyst Count
  • CGCT 0
  • TMCI 6
  • Target Price
  • CGCT N/A
  • TMCI $9.18
  • AVG Volume (30 Days)
  • CGCT 101.8K
  • TMCI 325.4K
  • Earning Date
  • CGCT 01-01-0001
  • TMCI 08-05-2025
  • Dividend Yield
  • CGCT N/A
  • TMCI N/A
  • EPS Growth
  • CGCT N/A
  • TMCI N/A
  • EPS
  • CGCT N/A
  • TMCI N/A
  • Revenue
  • CGCT N/A
  • TMCI $210,819,000.00
  • Revenue This Year
  • CGCT N/A
  • TMCI $10.61
  • Revenue Next Year
  • CGCT N/A
  • TMCI $10.36
  • P/E Ratio
  • CGCT N/A
  • TMCI N/A
  • Revenue Growth
  • CGCT N/A
  • TMCI 7.54
  • 52 Week Low
  • CGCT $10.00
  • TMCI $4.54
  • 52 Week High
  • CGCT $11.16
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • CGCT N/A
  • TMCI 55.03
  • Support Level
  • CGCT N/A
  • TMCI $5.54
  • Resistance Level
  • CGCT N/A
  • TMCI $6.24
  • Average True Range (ATR)
  • CGCT 0.00
  • TMCI 0.31
  • MACD
  • CGCT 0.00
  • TMCI 0.09
  • Stochastic Oscillator
  • CGCT 0.00
  • TMCI 90.11

About CGCT CARTESIAN GROWTH CORP III

Cartesian Growth Corp III is a blank check company.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: